Musk and Amodei: The Battle for the Soul of Artificial Intelligence — Hope vs. Control
Elon Musk has once again found himself at the center of the debate about the future of artificial intelligence, backing Anthropic CEO Dario Amodei in his harsh criticism of the industry. The billionaire's reaction came immediately—literally a minute after Amodei published a detailed post defending his warnings against accusations of excessive pessimism.
Why Amodei insists on AI risks
The dispute flared up after a statement by investor Gavin Baker, who noted that rumors about Amodei's position diverge from what he says publicly. However, the Anthropic chief countered: his work "Machines of Loving Grace" appeared precisely because the industry is overhyping things, creating a one-sided picture.
According to Amodei, the root of the problem lies in society's deep-seated distrust of corporations, government institutions, and the tech industry as a whole. This distrust, accumulated over decades, is automatically transferred to artificial intelligence. He also emphasized that brief interviews often look gloomier than they really are, since it is precisely such phrasing that garners more attention.
"The fairest criticism of AI companies, including Anthropic, is that we still haven't fulfilled the main promise: to bring benefit to the world," Amodei stated.
Musk enters the philosophical debate
Musk called the dialogue "interesting," but his own contribution turned out to be far more provocative. He essentially echoed Naval Ravikant's thought: you cannot create a god and put it on a leash. Musk's response sounded like a restrained admission of vulnerability: "I hope AI will be kind to us."
Hidden within this laconic tweet is a powerful warning: if humanity loses control over superintelligence, the only thing left to rely on is the goodwill of its own creation. This is not just rhetoric but a fundamental shift in perception—from confidence in technical safeguards to acknowledging existential uncertainty.
Musk's position is not new: he has previously criticized OpenAI's closed nature and noted that Amodei chose a different path. However, on the issue of regulation, their views diverge. Amodei supports California's SB 53 bill, which exempts companies with revenue below $500 million from requirements, while Musk doubts that regulation will not lead to a concentration of power in the hands of a few.
Against the backdrop of this dispute, Amodei reminded of two viable approaches: pre-testing models, proposed by the Trump administration, and creating an independent regulator modeled on FINRA, as suggested by Demis Hassabis. He himself returns to his most ambitious goal—AI could cure most diseases within 5–10 years, but, as he admits, what helps is not slogans but real treatment.
This dialogue is an indicator of the industry's maturity. When key figures discuss not only opportunities but also moral obligations to humanity, the market begins to account not only for technological but also ethical risks. For investors, this is a signal: the long-term value of AI projects will be determined not only by innovation but also by the industry's ability to earn society's trust.